Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-145
Closed -$28.1K – 292
2024
Q3
$28.1K Hold
145
– – 0.01% 242
2024
Q2
$33.6K Hold
145
– – 0.02% 236
2024
Q1
$31.3K Hold
145
– – 0.02% 234
2023
Q4
$37.5K Hold
145
– – 0.02% 225
2023
Q3
$37.3K Hold
145
– – 0.02% 222
2023
Q2
$39.2K Buy
+145
New +$43.2K 0.02% 219

Other funds holding BIIB

Union Savings Bank's BIIB Position: Q4 2024 in Review

Union Savings Bank sold out of Biogen (BIIB) in Q4 2024, closing a stake of 145 shares — an estimated $28.1K sold.

Union Savings Bank first reported a position in BIIB in Q2 2023 and held it in 6 quarters. The position peaked at $39.2K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Union Savings Bank reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Union Savings Bank sold 145 Biogen shares in Q4 2024, an estimated $28.1K.
  • Union Savings Bank first reported a position in Biogen in Q2 2023 and held it in 6 quarters.
  • Union Savings Bank's Biogen position peaked at $39.2K in Q2 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Union Savings Bank's 13F filing for Q4 2024, filed 16 Jan 2025.